IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 317 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $106,000 | -16.5% | 3,164 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $127,000 | -11.8% | 3,179 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $144,000 | -74.5% | 3,208 | -67.9% | 0.00% | -77.8% |
| Q4 2020 | $565,000 | -28.7% | 10,000 | -40.1% | 0.01% | -40.0% |
| Q3 2020 | $792,000 | -23.6% | 16,683 | -5.1% | 0.02% | -25.0% |
| Q2 2020 | $1,037,000 | +23.0% | 17,587 | -1.4% | 0.02% | 0.0% |
| Q1 2020 | $843,000 | -15.2% | 17,833 | +8.3% | 0.02% | +17.6% |
| Q4 2019 | $994,000 | -12.7% | 16,462 | -13.4% | 0.02% | -19.0% |
| Q3 2019 | $1,138,000 | -29.0% | 19,001 | -23.8% | 0.02% | -27.6% |
| Q2 2019 | $1,603,000 | -30.9% | 24,946 | -12.8% | 0.03% | -29.3% |
| Q1 2019 | $2,321,000 | +102.0% | 28,593 | +34.5% | 0.04% | +78.3% |
| Q4 2018 | $1,149,000 | +18.7% | 21,255 | +13.2% | 0.02% | +43.8% |
| Q3 2018 | $968,000 | +19.4% | 18,773 | -3.5% | 0.02% | +14.3% |
| Q2 2018 | $811,000 | -43.3% | 19,454 | -28.2% | 0.01% | -41.7% |
| Q1 2018 | $1,431,000 | +8.0% | 27,088 | +2.8% | 0.02% | +9.1% |
| Q4 2017 | $1,325,000 | +48.0% | 26,349 | +49.3% | 0.02% | +46.7% |
| Q3 2017 | $895,000 | +105.7% | 17,652 | +106.3% | 0.02% | +114.3% |
| Q2 2017 | $435,000 | +65.4% | 8,558 | +30.8% | 0.01% | +75.0% |
| Q1 2017 | $263,000 | +141.3% | 6,542 | +186.9% | 0.00% | +100.0% |
| Q4 2016 | $109,000 | -29.2% | 2,280 | -45.6% | 0.00% | -33.3% |
| Q3 2016 | $154,000 | +9.2% | 4,191 | -30.9% | 0.00% | +50.0% |
| Q2 2016 | $141,000 | -47.4% | 6,063 | -8.2% | 0.00% | -50.0% |
| Q1 2016 | $268,000 | -35.6% | 6,608 | -1.7% | 0.00% | -42.9% |
| Q4 2015 | $416,000 | – | 6,723 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |